We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HAE market cap is 3.26B. The company's latest EPS is USD 2.3400 and P/E is 27.75.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 336.25M | 343.29M | 336.17M | 345.51M | 348.54M |
| Operating Income | 45.98M | 27.94M | 39.76M | 51.7M | 44.93M |
| Net Income | 31.24M | 20.37M | 38.37M | 33.83M | 37.49M |
| Year End March 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 988.48M | 903.28M | 1B | 1.17B | 1.31B |
| Operating Income | 153.95M | 90.78M | 81.33M | 155.65M | 162.88M |
| Net Income | 76.53M | 79.47M | 43.38M | 115.4M | 117.56M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.2B | 2.2B | 2.54B | 2.53B | 2.53B |
| Total Liabilities | 1.26B | 1.24B | 1.64B | 1.65B | 1.62B |
| Total Equity | 943.32M | 959.96M | 905.37M | 878.85M | 906.86M |
| Year End March 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.27B | 1.82B | 1.86B | 1.93B | 2.2B |
| Total Liabilities | 680M | 1.09B | 1.11B | 1.12B | 1.24B |
| Total Equity | 587.11M | 731.67M | 749.42M | 818M | 959.96M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 117.67M | 181.75M | -27.42M | 21.4M | 65.17M |
| Investing | -309.33M | -322.39M | -139.2M | -162.56M | -179.94M |
| Financing | 101.66M | 38.16M | 333.69M | 258.89M | 260.27M |
| Year End March 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 158.22M | 108.81M | 172.26M | 273.06M | 181.75M |
| Investing | -57.18M | -425.44M | -86.35M | -143.79M | -322.39M |
| Financing | -131.21M | 367.45M | -15.75M | -100.36M | 38.16M |
| Market Cap | 3.26B |
| Price to Earnings Ratio | 27.75 |
| Price to Sales Ratio | 2.49 |
| Price to Cash Ratio | 18.24 |
| Price to Book Ratio | 3.4 |
| Dividend Yield | - |
| Shares Outstanding | 50.24M |
| Average Volume (1 week) | 857.24k |
| Average Volume (1 Month) | 1.38M |
| 52 Week Change | -11.38% |
| 52 Week High | 97.97 |
| 52 Week Low | 58.80 |
| Spread (Intraday) | 3.38 (5.13%) |
| Company Name | Haemonetics Corp |
| Address |
155 federal street boston, massachusetts 02110 |
| Website | https://www.haemonetics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
